Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997
|
| 12/20/2005 |
  |
Rigel Advances Clinical Development Programs for R788 and R763 |
|
| 12/8/2005 |
|
Rigel to Host Investor Briefing on December 15, 2005 |
|
| 12/7/2005 |
|
Rigel’s R406/788 Shows Promise for Treating Immune Thrombocytopenia, Hemolytic Anemia and Myeloid Leukemia in Preclinical Studies |
|
| 12/1/2005 |
|
Rigel Announces Disappointing Results from Phase II Study of R112 for the Treatment of Allergic Rhinitis |
|
| 11/28/2005 |
|
Rigel Describes Role of UHRF1, a Ubiquitin Ligase, in Tumor Growth |
|
| 11/14/2005 |
|
Rigel Announces Presentation of Phase I Data on R406/788 at the American College of Rheumatology (ACR) Annual Meeting |
|
| 11/9/2005 |
|
Rigel to Present at Upcoming Investor Conferences |
|
| 11/8/2005 |
|
Rigel Announces Third Quarter 2005 Financial Results |
|
| 11/3/2005 |
|
Rigel Announces Publications Highlighting Two New Screening Mechanisms for Ubiquitin Ligase Inhibitors |
|
| 10/27/2005 |
|
Rigel Announces Presentations at American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting |
|
| 10/25/2005 |
|
Serono and Rigel Sign Agreement to Develop and Commercialize Aurora Kinase Inhibitors |
|
| 10/18/2005 |
|
Rigel Discovers Novel Angiogenesis and Tumor Formation Roles of Axl Kinase |
|
| 10/12/2005 |
|
Rigel to Present at 2005 BIO Investor Forum |
|
| 10/5/2005 |
|
Rigel Announces Changes to Board of Directors and Appoints Gary A. Lyons |
|
| 9/21/2005 |
|
Rigel to Present at 2005 UBS Life Sciences Conference |
|
| 9/12/2005 |
|
Rigel Announces Presentation at UCSD Frontiers of Clinical Investigation Symposium |
|
| 8/31/2005 |
|
Rigel to Present at Upcoming Investor Conferences |
|
| 8/9/2005 |
|
Rigel Initiates Comparative Phase II Clinical Trial of R112 for the Treatment of Allergies |
|
| 8/3/2005 |
|
Rigel Announces Second Quarter 2005 Financial Results |
|
| 7/26/2005 |
|
Rigel to Present at the Adams Harkness 25th Annual Summer Seminar on Thursday, August 4th |
|
| 7/22/2005 |
|
Rigel to Present at the 2005 FASEB Summer Research Conference |
|
| 7/21/2005 |
|
Rigel Announces Closing of Public Offering of Common Stock |
|
| 7/15/2005 |
|
Rigel Announces Pricing of Common Stock Offering |
|
| 7/11/2005 |
|
Rigel Announces Offering of 3,000,000 Shares of Common Stock |
|
| 7/6/2005 |
|
Rigel’s Productivity on Track: HCV and R&D Pipeline Update |
|
| 6/10/2005 |
|
Rigel to Presents at Upcoming Investors Conferences |
|
| 6/2/2005 |
|
Rigel to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference |
|
| 5/23/2005 |
|
Rigel to Present at Fourth Annual Needham Biotechnology Conference |
|
| 5/19/2005 |
|
Rigel to Present at UBS Global Pharmaceuticals Conference |
|
| 5/12/2005 |
|
Rigel to Present at Banc of America Securities Healthcare Conference |
|
| 5/6/2005 |
|
Rigel to Present at Bear Stearns 2005 London Healthcare Conference |
|
| 5/5/2005 |
|
Rigel Receives Two Milestone Payments from Daiichi |
|
| 5/3/2005 |
|
Rigel Announces First Quarter 2005 Financial Results |
|
| 4/27/2005 |
|
Rigel to Present at the Deutsche Bank Securities 30th Annual Healthcare Conference on May 2, 2005 |
|
| 4/22/2005 |
|
Rigel to Present at 5th Annual Fortis Bank Biotech Conference on April 27, 2005 |
|
| 4/15/2005 |
|
Rigel Announces Presentations at the 96th Annual Meeting of the American Association for Cancer Research (AACR) |
|
| 4/14/2005 |
|
Rigel to Present at White Mountain Capital Third Annual Biotechnology Conference on April 19, 2005 |
|
| 4/6/2005 |
|
Efficacy and Safety Clinical Data for Rigel's R112 Phase II Study Published in Journal of Allergy and Clinical Immunology |
|
| 3/31/2005 |
|
Rigel Completes Phase I Clinical Trial of R406 in Rheumatoid Arthritis |
|
| 3/24/2005 |
|
Rigel to Present at the Lehman Brothers Eighth Annual Global Healthcare Conference on March 31, 2005 |
|
| 3/17/2005 |
|
Rigel Presents Clinical Data at the American Academy of Allergy, Asthma and Immunology |
|
| 2/24/2005 |
|
Rigel to Present at Wells Fargo Securities 2005 Healthcare Conference |
|
| 2/17/2005 |
|
Rigel to Present at BIO CEO & Investor Conference on February 24, 2005 |
|
| 2/8/2005 |
|
Rigel Announces Fourth Quarter and Year End 2004 Financial Results |
|
| 2/3/2005 |
|
Rigel Pharmaceuticals Announces Changes to Board of Directors and Appoints Peter S. Ringrose, Ph.D. |
|
| 1/20/2005 |
|
Rigel and Pfizer Sign Collaborative Research and License Agreement for the Treatment of Allergic Asthma and Other Respiratory Diseases |
|
| 1/7/2005 |
|
Rigel to Present at the 23rd Annual JPMorgan Healthcare Conference on January 13, 2005 |
|
rigel in the news
